Carcinogenesis Advance Access published online on January 3, 2008
Carcinogenesis, doi:10.1093/carcin/bgm275
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NO-donating aspirin inhibits the activation of NF-
B in human cancer cell lines and Min mice
Division of Cancer Prevention, Department of Medicine, State University of New York at Stony Brook, Stony Brook, New York 11794-5200
Corresponding author: Basil Rigas, Division of Cancer Prevention, SUNY at Stony Brook, Life Sciences Building, Room 006, Stony Brook, NY 11794-5200, Tel: 631-632-9035; Fax: 631-632-1992; e-mail: basil.rigas{at}stonybrook.edu
Nitric oxide-donating aspirin (NO-ASA) is a promising agent for the control of cancer, whose mechanism of action remains unclear. NF-
B is an important signaling molecule in the pathogenesis of cancer. We studied in several human colon (HT-29, HCT-15, LoVo, HCT116, SW-480), pancreatic (BxPC-3, MIA PaCa-2) and breast (MDA-MB231, MCF7) cancer cell lines, the effect of NO-ASA on NF-
B activation, determined by electrophoretic mobility shift assays (EMSAs), immunofluorescence, and Western blot analyses of nuclear proteins. NO-ASA inhibited NF-
B activation, as early as 30 minutes and with IC50s ranging between 0.83 and 64 µM. Such inhibition was also observed at NO-ASA concentrations that had an insignificant or marginal effect on cell growth. The effect of NO-ASA on NF-
B binding to DNA was significantly correlated with its effect on cell growth (P<0.05) indicating that the growth inhibitory effect of NO-ASA may be mediated by its effect on NF-
B. Compared to control, NO-ASA decreased NF-
B activation in intestinal epithelial cells of APCmin mice by 38.4% (P<0.01). Western and immunofluorescence analyses revealed that the nuclear levels of the p50 and p65 NF-
B subunits were virtually unaffected, suggesting an inhibitory mechanism different from suppressed subunit translocation into the nucleus. Inhibition of NF-
B activation by NO-ASA may account, at least in part, for its chemopreventive efficacy.
Received August 3, 2007; revised November 26, 2007; accepted November 26, 2007.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Ramadoss, E. R. Lunde, N. Ouyang, W.-J. A. Chen, and T. A. Cudd Acid-sensitive channel inhibition prevents fetal alcohol spectrum disorders cerebellar Purkinje cell loss Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R596 - R603. [Abstract] [Full Text] [PDF] |
||||
